Welcome to our dedicated page for Rain Enhancement SEC filings (Ticker: RAIN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking Rain Oncology’s push to reactivate the p53 tumor-suppressor pathway with its lead drug milademetan means wading through dense biotech disclosures. Clinical endpoints, cash runway projections and merger terms with Pathos AI are scattered across 8-K exhibits and 300-page 10-K sections. If you’ve ever typed “Rain Oncology SEC filings explained simply” or searched for the next “Rain Oncology quarterly earnings report 10-Q filing,” you know the challenge.
Stock Titan solves it. Our AI-powered summaries translate scientific jargon and accounting footnotes into plain language, spotlighting what matters: study readouts, milestone payments and dilution risk. With real-time EDGAR feeds, you’ll see every “Rain Oncology 8-K material events explained” notice the instant it posts and receive alerts for “Rain Oncology insider trading Form 4 transactions.” Whether you’re understanding Rain Oncology SEC documents with AI for the first time or monitoring positions daily, we cover every filing type—annual reports, 10-Qs, S-3 shelves and more—so nothing slips past.
Dig deeper with tailored tools. One click reveals cash-burn trends from the latest “Rain Oncology earnings report filing analysis,” while another surfaces board-level pay in the “Rain Oncology proxy statement executive compensation.” Track “Rain Oncology executive stock transactions Form 4” side by side with trial timelines to gauge management conviction. Planning an entry or exit? Compare quarter-over-quarter R&D spend in seconds, monitor “Rain Oncology Form 4 insider transactions real-time,” and read our plain-English take on the “Rain Oncology annual report 10-K simplified.” Complex oncology filings become actionable insights—delivered by AI and verified by experts.
Rain Enhancement Technologies Holdco, Inc. filed a prospectus supplement updating its registration for the potential issuance of 5,000,000 shares of Class A common stock underlying warrants and the resale of 5,914,057 Class A shares. The supplement attaches the company’s latest Quarterly Report on Form 10-Q for the period ended September 30, 2025.
As of September 30, 2025, the company had total assets of about $1.9 million, cash of roughly $237,000 and a working capital deficit of about $10.1 million, with total liabilities of about $11.5 million and a stockholders’ deficit of about $9.6 million. It reported a net loss of approximately $2.2 million for the quarter and $4.6 million for the nine-month period, with no revenue to date and expenses driven mainly by general and administrative costs, installation and research and development.
The company depends heavily on related-party financing, including a line of credit with about $6.6 million outstanding as of September 30, 2025, and has received a going concern warning due to limited liquidity and continued losses. RAIN’s Class A common stock and warrants continue to trade on Nasdaq, now listed on the Nasdaq Capital Market after a successful transfer that cured earlier market-value listing deficiencies.
Rain Enhancement Technologies Holdco (NASDAQ: RAIN) reported a net loss of $2.2 million for the three months ended September 30, 2025, and $4.6 million for the nine‑month period. The company ended the quarter with $236,735 in cash and a working capital deficit of about $10.1 million, and disclosed substantial doubt about its ability to continue as a going concern.
Current liabilities were $10.7 million versus total assets of $1.94 million, including a related‑party line of credit balance of $6.6 million and warrant liabilities of $825,000. The company recorded a non‑cash loss of $312,500 from changes in warrant fair value and $243,000 in interest expense in the quarter. RAIN’s listing was transferred from the Nasdaq Global Market to the Nasdaq Capital Market, with Nasdaq indicating the prior MVLS/MVPHS deficiencies are cured. Two fully built rain generation systems began installation late in the quarter and were placed in service in early November 2025; the company has not yet generated revenue.
Rain Enhancement Technologies Holdco, Inc. filed a prospectus supplement covering 5,000,000 shares of Class A Common Stock underlying warrants for issuance and 5,914,057 shares of Class A Common Stock for resale.
The company received a letter on November 5, 2025 from Nasdaq confirming it has demonstrated compliance with the Nasdaq Capital Market listing rules. On October 21, 2025, Nasdaq approved the company’s application to phase down the listing of its Class A Common Stock and Warrants from the Nasdaq Global Market to the Nasdaq Capital Market.
Class A Common Stock and Warrants trade on the Nasdaq Capital Market under RAIN and RAINW. On November 6, 2025, the Class A Common Stock closed at $4.99 per share and the Warrants closed at $0.16 per Warrant.
Rain Enhancement Technologies Holdco, Inc. (RAIN) announced it has regained compliance with Nasdaq listing requirements. Nasdaq also approved the Company’s application to “phase down” its listing from the Nasdaq Global Market to the Nasdaq Capital Market.
The Company’s Class A common stock will continue to trade under the symbol RAIN, and its redeemable warrants will continue under RAINW. Nasdaq’s confirmation of compliance was communicated on November 5, 2025, and the Company furnished a press release on November 7, 2025.
This update preserves the Company’s Nasdaq listing while moving to a market tier designed for smaller issuers, with no change to trading symbols.
Insider sales by a company director: Lyman B. Dickerson, a director of Rain Enhancement Technologies Holdco, Inc. (ticker RAIN), reported four open-market sales of Class A common stock across 09/09/2025–09/12/2025. The filings report dispositions of 1,917; 215; 398; and 4,787 shares at weighted-average prices of $5.24, $5.55, $5.80, and $5.78, respectively, reflecting reported price ranges for each day. After these transactions the reporting person beneficially owned 10,247 shares as of the last sale. The report includes an undertaking to provide details of the number of shares sold at each separate price on request.
FAQ
What is the current stock price of Rain Enhancement (RAIN)?
What is the market cap of Rain Enhancement (RAIN)?
